speb/financial-data huggingface dataset:
PATH income_statement (annual, 2025-01-31) — Interest Income Non Operating: 49422000.00
PATH income_statement (quarterly, 2025-01-31) — Interest Income Non Operating: 12167000.00
PATH cash_flow (annual, 2025-01-31) — Interest Paid Supplemental Data: 309000.00
PATH cash_flow (quarterly, 2025-01-31) — Interest Paid Supplemental Data: 0.00
PATH balance_sheet (annual, 2025-01-31) — Invested Capital: 1845762000.00
PATH balance_sheet (quarterly, 2025-01-31) — Invested Capital: 1845762000.00
PATH cash_flow (annual, 2025-01-31) — Investing Cash Flow: -45503000.00
PATH cash_flow (quarterly, 2025-01-31) — Investing Cash Flow: -16696000.00
PATH balance_sheet (annual, 2025-01-31) — Investmentin Financial Assets: 94113000.00
PATH balance_sheet (quarterly, 2025-01-31) — Investmentin Financial Assets: 94113000.00
PATH balance_sheet (annual, 2025-01-31) — Investments And Advances: 94113000.00
PATH balance_sheet (quarterly, 2025-01-31) — Investments And Advances: 94113000.00
PATH balance_sheet (annual, 2025-01-31) — Leases: 31402000.00
PATH balance_sheet (quarterly, 2025-01-31) — Leases: 31402000.00
PATH balance_sheet (annual, 2025-01-31) — Long Term Capital Lease Obligation: 74230000.00
PATH balance_sheet (quarterly, 2025-01-31) — Long Term Capital Lease Obligation: 74230000.00
PATH balance_sheet (annual, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 74230000.00
PATH balance_sheet (quarterly, 2025-01-31) — Long Term Debt And Capital Lease Obligation: 74230000.00
PATH balance_sheet (annual, 2025-01-31) — Long Term Equity Investment: 24400000.00
PATH balance_sheet (quarterly, 2025-01-31) — Long Term Equity Investment: 24400000.00
PATH balance_sheet (annual, 2025-01-31) — Machinery Furniture Equipment: 30801000.00
PATH balance_sheet (quarterly, 2025-01-31) — Machinery Furniture Equipment: 30801000.00
PATH cash_flow (annual, 2025-01-31) — Net Business Purchase And Sale: 0.00
PATH cash_flow (annual, 2025-01-31) — Net Common Stock Issuance: -390751000.00
PATH cash_flow (quarterly, 2025-01-31) — Net Common Stock Issuance: -9348000.00
PATH income_statement (annual, 2025-01-31) — Net Income: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Net Income: 51794000.00
PATH income_statement (annual, 2025-01-31) — Net Income Common Stockholders: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Net Income Common Stockholders: 51794000.00
PATH income_statement (annual, 2025-01-31) — Net Income Continuous Operations: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Net Income Continuous Operations: 51794000.00
PATH income_statement (annual, 2025-01-31) — Net Income From Continuing And Discontinued Operation: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Net Income From Continuing And Discontinued Operation: 51794000.00
PATH income_statement (annual, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 51794000.00
PATH cash_flow (annual, 2025-01-31) — Net Income From Continuing Operations: -73694000.00
PATH cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 51794000.00
PATH income_statement (annual, 2025-01-31) — Net Income Including Noncontrolling Interests: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 51794000.00
PATH income_statement (annual, 2025-01-31) — Net Interest Income: 49422000.00
PATH income_statement (quarterly, 2025-01-31) — Net Interest Income: 12167000.00
PATH cash_flow (annual, 2025-01-31) — Net Investment Purchase And Sale: 5229000.00
PATH cash_flow (quarterly, 2025-01-31) — Net Investment Purchase And Sale: -9304000.00
PATH income_statement (annual, 2025-01-31) — Net Non Operating Interest Income Expense: 49422000.00
PATH income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: 12167000.00
PATH cash_flow (annual, 2025-01-31) — Net Other Financing Charges: -83401000.00
PATH cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: -17447000.00
PATH cash_flow (annual, 2025-01-31) — Net Other Investing Changes: -35809000.00
PATH balance_sheet (annual, 2025-01-31) — Net PPE: 99240000.00
PATH balance_sheet (quarterly, 2025-01-31) — Net PPE: 99240000.00
PATH cash_flow (annual, 2025-01-31) — Net PPE Purchase And Sale: -14923000.00
PATH cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -7392000.00
PATH balance_sheet (annual, 2025-01-31) — Net Tangible Assets: 1750553000.00
PATH balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: 1750553000.00
PATH balance_sheet (annual, 2025-01-31) — Non Current Accounts Receivable: 3447000.00
PATH balance_sheet (quarterly, 2025-01-31) — Non Current Accounts Receivable: 3447000.00
PATH balance_sheet (annual, 2025-01-31) — Non Current Deferred Assets: 167304000.00
PATH balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Assets: 167304000.00
PATH balance_sheet (annual, 2025-01-31) — Non Current Deferred Liabilities: 135843000.00
PATH balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 135843000.00
PATH balance_sheet (annual, 2025-01-31) — Non Current Deferred Revenue: 135843000.00
PATH balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Revenue: 135843000.00
PATH balance_sheet (annual, 2025-01-31) — Non Current Deferred Taxes Assets: 27963000.00
PATH balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Assets: 27963000.00
PATH income_statement (annual, 2025-01-31) — Normalized EBITDA: -145337000.00
PATH income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 36824000.00
PATH income_statement (annual, 2025-01-31) — Normalized Income: -73694000.00
PATH income_statement (quarterly, 2025-01-31) — Normalized Income: 51794000.00
PATH cash_flow (annual, 2025-01-31) — Operating Cash Flow: 320565000.00
PATH cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 146082000.00
PATH income_statement (annual, 2025-01-31) — Operating Income: -162569000.00
PATH income_statement (quarterly, 2025-01-31) — Operating Income: 33609000.00
PATH income_statement (annual, 2025-01-31) — Operating Revenue: 1429664000.00
PATH income_statement (quarterly, 2025-01-31) — Operating Revenue: 423646000.00
PATH balance_sheet (annual, 2025-01-31) — Ordinary Shares Number: 553511748.00
PATH balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 553511748.00
PATH balance_sheet (annual, 2025-01-31) — Other Current Assets: 20942000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 20942000.00
PATH balance_sheet (annual, 2025-01-31) — Other Current Liabilities: 25648000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Current Liabilities: 25648000.00
PATH balance_sheet (annual, 2025-01-31) — Other Equity Adjustments: -4890000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: -4890000.00
PATH income_statement (annual, 2025-01-31) — Other Gand A: 226116000.00
PATH income_statement (quarterly, 2025-01-31) — Other Gand A: 48997000.00
PATH income_statement (annual, 2025-01-31) — Other Income Expense: 35047000.00
PATH income_statement (quarterly, 2025-01-31) — Other Income Expense: 8848000.00
PATH balance_sheet (annual, 2025-01-31) — Other Intangible Assets: 7905000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Intangible Assets: 7905000.00
PATH cash_flow (annual, 2025-01-31) — Other Non Cash Items: 110241000.00
PATH cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 31000000.00
PATH balance_sheet (annual, 2025-01-31) — Other Non Current Assets: 67398000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 67398000.00
PATH balance_sheet (annual, 2025-01-31) — Other Non Current Liabilities: 10515000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 10515000.00
PATH income_statement (annual, 2025-01-31) — Other Non Operating Income Expenses: 35047000.00
PATH income_statement (quarterly, 2025-01-31) — Other Non Operating Income Expenses: 8848000.00
PATH balance_sheet (annual, 2025-01-31) — Other Properties: 67135000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Properties: 67135000.00
PATH balance_sheet (annual, 2025-01-31) — Other Receivables: 88735000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Receivables: 88735000.00
PATH balance_sheet (annual, 2025-01-31) — Other Short Term Investments: 750322000.00
PATH balance_sheet (quarterly, 2025-01-31) — Other Short Term Investments: 750322000.00
PATH balance_sheet (annual, 2025-01-31) — Payables: 64721000.00
PATH balance_sheet (quarterly, 2025-01-31) — Payables: 64721000.00
PATH balance_sheet (annual, 2025-01-31) — Payables And Accrued Expenses: 84531000.00
PATH balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 84531000.00
PATH balance_sheet (annual, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 115690000.00
PATH balance_sheet (quarterly, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 115690000.00
PATH balance_sheet (annual, 2025-01-31) — Preferred Stock: 0.00
PATH balance_sheet (quarterly, 2025-01-31) — Preferred Stock: 0.00
PATH balance_sheet (annual, 2025-01-31) — Prepaid Assets: 65334000.00
PATH balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 65334000.00
PATH income_statement (annual, 2025-01-31) — Pretax Income: -78100000.00
PATH income_statement (quarterly, 2025-01-31) — Pretax Income: 54624000.00
PATH cash_flow (annual, 2025-01-31) — Proceeds From Stock Option Exercised: 23637000.00
PATH cash_flow (quarterly, 2025-01-31) — Proceeds From Stock Option Exercised: 9810000.00
PATH balance_sheet (annual, 2025-01-31) — Properties: 0.00
PATH balance_sheet (quarterly, 2025-01-31) — Properties: 0.00
PATH cash_flow (annual, 2025-01-31) — Provisionand Write Offof Assets: 1979000.00
PATH cash_flow (annual, 2025-01-31) — Purchase Of Business: 0.00
PATH cash_flow (annual, 2025-01-31) — Purchase Of Investment: -1470355000.00
PATH cash_flow (quarterly, 2025-01-31) — Purchase Of Investment: -308112000.00
PATH cash_flow (annual, 2025-01-31) — Purchase Of PPE: -14923000.00
PATH cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -7392000.00
PATH balance_sheet (annual, 2025-01-31) — Receivables: 539866000.00
PATH balance_sheet (quarterly, 2025-01-31) — Receivables: 539866000.00
PATH income_statement (annual, 2025-01-31) — Reconciled Cost Of Revenue: 246942000.00
PATH income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 64534000.00
PATH income_statement (annual, 2025-01-31) — Reconciled Depreciation: 17232000.00
PATH income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 3215000.00
PATH cash_flow (annual, 2025-01-31) — Repurchase Of Capital Stock: -390751000.00
PATH cash_flow (quarterly, 2025-01-31) — Repurchase Of Capital Stock: -9348000.00
PATH income_statement (annual, 2025-01-31) — Research And Development: 380682000.00
PATH income_statement (quarterly, 2025-01-31) — Research And Development: 99670000.00
PATH balance_sheet (annual, 2025-01-31) — Restricted Cash: 438000.00
PATH balance_sheet (quarterly, 2025-01-31) — Restricted Cash: 438000.00
PATH balance_sheet (annual, 2025-01-31) — Retained Earnings: -1987875000.00
PATH balance_sheet (quarterly, 2025-01-31) — Retained Earnings: -1987875000.00
PATH cash_flow (annual, 2025-01-31) — Sale Of Investment: 1475584000.00
PATH cash_flow (quarterly, 2025-01-31) — Sale Of Investment: 298808000.00
PATH income_statement (annual, 2025-01-31) — Selling And Marketing Expense: 738493000.00
PATH income_statement (quarterly, 2025-01-31) — Selling And Marketing Expense: 176836000.00
PATH income_statement (annual, 2025-01-31) — Selling General And Administration: 964609000.00
PATH income_statement (quarterly, 2025-01-31) — Selling General And Administration: 225833000.00
PATH balance_sheet (annual, 2025-01-31) — Share Issued: 591132748.00
PATH balance_sheet (quarterly, 2025-01-31) — Share Issued: 591132748.00
PATH cash_flow (annual, 2025-01-31) — Stock Based Compensation: 358151000.00
PATH cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 87631000.00
PATH balance_sheet (annual, 2025-01-31) — Stockholders Equity: 1845762000.00
PATH balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 1845762000.00
PATH balance_sheet (annual, 2025-01-31) — Tangible Book Value: 1750553000.00
PATH balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: 1750553000.00
PATH income_statement (annual, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (annual, 2025-01-31) — Tax Provision: -4406000.00
PATH income_statement (quarterly, 2025-01-31) — Tax Provision: 2830000.00
PATH income_statement (annual, 2025-01-31) — Tax Rate For Calcs: 0.06
PATH income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.05
PATH balance_sheet (annual, 2025-01-31) — Total Assets: 2865270000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Assets: 2865270000.00
PATH balance_sheet (annual, 2025-01-31) — Total Capitalization: 1845762000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 1845762000.00
PATH balance_sheet (annual, 2025-01-31) — Total Debt: 77817000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Debt: 77817000.00
PATH balance_sheet (annual, 2025-01-31) — Total Equity Gross Minority Interest: 1845762000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 1845762000.00
PATH income_statement (annual, 2025-01-31) — Total Expenses: 1592233000.00
PATH income_statement (quarterly, 2025-01-31) — Total Expenses: 390037000.00
PATH balance_sheet (annual, 2025-01-31) — Total Liabilities Net Minority Interest: 1019508000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 1019508000.00
PATH balance_sheet (annual, 2025-01-31) — Total Non Current Assets: 526711000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 526711000.00
PATH balance_sheet (annual, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 220588000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 220588000.00
PATH income_statement (annual, 2025-01-31) — Total Operating Income As Reported: -162569000.00
PATH income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 33609000.00
PATH balance_sheet (annual, 2025-01-31) — Total Tax Payable: 18229000.00
PATH balance_sheet (quarterly, 2025-01-31) — Total Tax Payable: 18229000.00
PATH balance_sheet (annual, 2025-01-31) — Treasury Shares Number: 37621000.00
PATH balance_sheet (quarterly, 2025-01-31) — Treasury Shares Number: 37621000.00
PATH balance_sheet (annual, 2025-01-31) — Treasury Stock: 494779000.00
PATH balance_sheet (quarterly, 2025-01-31) — Treasury Stock: 494779000.00
PATH balance_sheet (annual, 2025-01-31) — Working Capital: 1539639000.00
PATH balance_sheet (quarterly, 2025-01-31) — Working Capital: 1539639000.00
PATH income_statement (quarterly, 2025-04-30) — +Operating Expense: 309179000.00
PATH income_statement (quarterly, 2025-04-30) — +Total Revenue: 356624000.00
PATH balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 16885000.00
PATH balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 266619000.00
PATH balance_sheet (quarterly, 2025-04-30) — Accumulated Depreciation: -42751000.00
PATH balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 4403586000.00
PATH balance_sheet (quarterly, 2025-04-30) — Allowance For Doubtful Accounts Receivable: -1924000.00
PATH cash_flow (quarterly, 2025-04-30) — Amortization Of Securities: -3630000.00
PATH balance_sheet (quarterly, 2025-04-30) — Available For Sale Securities: 36467000.00
PATH income_statement (quarterly, 2025-04-30) — Basic Average Shares: 548451000.00
PATH income_statement (quarterly, 2025-04-30) — Basic EPS: -0.04
PATH cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 879634000.00
PATH cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -12832000.00
PATH balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 78952000.00
PATH balance_sheet (quarterly, 2025-04-30) — Capital Stock: 6000.00
PATH balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 700641000.00
PATH balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 1555033000.00
PATH cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -235204000.00
PATH cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -79923000.00
PATH cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 119002000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -15025000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Accrued Expense: -60182000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Other Current Liabilities: -2146000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: -74215000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Payable: -15025000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -75207000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Prepaid Assets: -13074000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Receivables: 187983000.00
PATH cash_flow (quarterly, 2025-04-30) — Change In Working Capital: 23341000.00
PATH cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: 197443000.00
PATH cash_flow (quarterly, 2025-04-30) — Changes In Cash: -196125000.00
PATH balance_sheet (quarterly, 2025-04-30) — Common Stock: 6000.00
PATH balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 1698461000.00
PATH cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -227525000.00
PATH balance_sheet (quarterly, 2025-04-30) — Construction In Progress: 18761000.00
PATH income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 63857000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 37467000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Assets: 2109669000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 5519000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 5519000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Deferred Assets: 85162000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 538857000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 530857000.00
PATH balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 715867000.00
PATH cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: 640000.00
PATH cash_flow (quarterly, 2025-04-30) — Deferred Tax: 640000.00
PATH cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 3253000.00
PATH cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 3253000.00
PATH income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 548451000.00
PATH income_statement (quarterly, 2025-04-30) — Diluted EPS: -0.04
PATH income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: -22555000.00
PATH balance_sheet (quarterly, 2025-04-30) — Dueto Related Parties Current: 16751000.00
PATH income_statement (quarterly, 2025-04-30) — EBIT: -16412000.00
PATH income_statement (quarterly, 2025-04-30) — EBITDA: -13159000.00
PATH cash_flow (quarterly, 2025-04-30) — Effect Of Exchange Rate Changes: 17570000.00
PATH cash_flow (quarterly, 2025-04-30) — End Cash Position: 701079000.00
PATH cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -235204000.00
PATH cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 106170000.00
PATH balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 29523000.00
PATH income_statement (quarterly, 2025-04-30) — General And Administrative Expense: 54679000.00
PATH balance_sheet (quarterly, 2025-04-30) — Goodwill: 121371000.00
PATH balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 145425000.00
PATH balance_sheet (quarterly, 2025-04-30) — Gross Accounts Receivable: 268543000.00
PATH balance_sheet (quarterly, 2025-04-30) — Gross PPE: 151014000.00
PATH income_statement (quarterly, 2025-04-30) — Gross Profit: 292767000.00
PATH cash_flow (quarterly, 2025-04-30) — Income Tax Paid Supplemental Data: 6052000.00
PATH balance_sheet (quarterly, 2025-04-30) — Income Tax Payable: 3616000.00
PATH income_statement (quarterly, 2025-04-30) — Interest Income: 12648000.00
PATH income_statement (quarterly, 2025-04-30) — Interest Income Non Operating: 12648000.00
PATH cash_flow (quarterly, 2025-04-30) — Interest Paid Supplemental Data: 0.00
PATH balance_sheet (quarterly, 2025-04-30) — Invested Capital: 1698461000.00
PATH cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -79923000.00
PATH balance_sheet (quarterly, 2025-04-30) — Investmentin Financial Assets: 36467000.00
PATH balance_sheet (quarterly, 2025-04-30) — Investments And Advances: 36467000.00
PATH balance_sheet (quarterly, 2025-04-30) — Leases: 32376000.00
PATH balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 73433000.00
PATH balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 73433000.00
PATH balance_sheet (quarterly, 2025-04-30) — Machinery Furniture Equipment: 32897000.00
PATH cash_flow (quarterly, 2025-04-30) — Net Business Purchase And Sale: -24821000.00
PATH cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -227525000.00
PATH income_statement (quarterly, 2025-04-30) — Net Income: -22555000.00
PATH income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: -22555000.00
PATH income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: -22555000.00
PATH income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: -22555000.00
PATH income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: -22555000.00
PATH cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: -22555000.00
PATH income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: -22555000.00
PATH income_statement (quarterly, 2025-04-30) — Net Interest Income: 12648000.00
PATH cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: -42270000.00
PATH income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: 12648000.00
PATH cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -12195000.00
PATH balance_sheet (quarterly, 2025-04-30) — Net PPE: 108263000.00
PATH cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -12832000.00
PATH balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: 1553036000.00
PATH balance_sheet (quarterly, 2025-04-30) — Non Current Accounts Receivable: 2811000.00
PATH balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Assets: 167872000.00
PATH balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 141169000.00
PATH balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Revenue: 141169000.00
PATH balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Assets: 29491000.00
PATH income_statement (quarterly, 2025-04-30) — Normalized EBITDA: -13159000.00
PATH income_statement (quarterly, 2025-04-30) — Normalized Income: -22555000.00
PATH cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 119002000.00
PATH income_statement (quarterly, 2025-04-30) — Operating Income: -16412000.00
PATH income_statement (quarterly, 2025-04-30) — Operating Revenue: 356624000.00
PATH balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 534869748.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 32616000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Current Liabilities: 28674000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: 29523000.00
PATH income_statement (quarterly, 2025-04-30) — Other Gand A: 54679000.00
PATH income_statement (quarterly, 2025-04-30) — Other Income Expense: -15964000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Intangible Assets: 24054000.00
PATH cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 41592000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 73935000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 15512000.00
PATH income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: -15964000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Properties: 66980000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Receivables: 103150000.00
PATH balance_sheet (quarterly, 2025-04-30) — Other Short Term Investments: 854392000.00
PATH balance_sheet (quarterly, 2025-04-30) — Payables: 52600000.00
PATH balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 90067000.00
PATH balance_sheet (quarterly, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 52750000.00
PATH balance_sheet (quarterly, 2025-04-30) — Preferred Stock: 0.00
PATH balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 66651000.00
PATH income_statement (quarterly, 2025-04-30) — Pretax Income: -19728000.00
PATH cash_flow (quarterly, 2025-04-30) — Proceeds From Stock Option Exercised: 4516000.00
PATH balance_sheet (quarterly, 2025-04-30) — Properties: 0.00
PATH cash_flow (quarterly, 2025-04-30) — Purchase Of Business: -24821000.00
PATH cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: -153353000.00
PATH cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -12832000.00
PATH balance_sheet (quarterly, 2025-04-30) — Receivables: 369769000.00
PATH income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 63857000.00
PATH income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 3253000.00
PATH cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -227525000.00
PATH income_statement (quarterly, 2025-04-30) — Research And Development: 94839000.00
PATH balance_sheet (quarterly, 2025-04-30) — Restricted Cash: 438000.00
PATH balance_sheet (quarterly, 2025-04-30) — Retained Earnings: -2010430000.00
PATH cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 111083000.00
PATH income_statement (quarterly, 2025-04-30) — Selling And Marketing Expense: 159661000.00
PATH income_statement (quarterly, 2025-04-30) — Selling General And Administration: 214340000.00
PATH balance_sheet (quarterly, 2025-04-30) — Share Issued: 594365748.00
PATH cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 76361000.00
PATH balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 1698461000.00
PATH balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: 1553036000.00
PATH income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (quarterly, 2025-04-30) — Tax Provision: 2827000.00
PATH income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.21
PATH balance_sheet (quarterly, 2025-04-30) — Total Assets: 2644442000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 1698461000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Debt: 78952000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 1698461000.00
PATH income_statement (quarterly, 2025-04-30) — Total Expenses: 373036000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 945981000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 534773000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 230114000.00
PATH income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: -16412000.00
PATH balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 18964000.00
PATH balance_sheet (quarterly, 2025-04-30) — Treasury Shares Number: 59496000.00
PATH balance_sheet (quarterly, 2025-04-30) — Treasury Stock: 724224000.00
PATH balance_sheet (quarterly, 2025-04-30) — Working Capital: 1393802000.00
PATH income_statement (quarterly, 2025-07-31) — +Operating Expense: 317533000.00
PATH income_statement (quarterly, 2025-07-31) — +Total Revenue: 361728000.00
PATH balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 19743000.00
PATH balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 269810000.00
PATH balance_sheet (quarterly, 2025-07-31) — Accumulated Depreciation: -42926000.00
PATH balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 4474638000.00
PATH balance_sheet (quarterly, 2025-07-31) — Allowance For Doubtful Accounts Receivable: -2487000.00
PATH cash_flow (quarterly, 2025-07-31) — Amortization Of Securities: -3332000.00
PATH balance_sheet (quarterly, 2025-07-31) — Available For Sale Securities: 75151000.00
PATH income_statement (quarterly, 2025-07-31) — Basic Average Shares: 536169000.00
PATH income_statement (quarterly, 2025-07-31) — Basic EPS: 0.00
PATH cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 701079000.00
PATH balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 79310000.00
PATH balance_sheet (quarterly, 2025-07-31) — Capital Stock: 6000.00
PATH balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 628617000.00
PATH balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 1447487000.00
PATH cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -111602000.00
PATH cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: -655000.00
PATH cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 41587000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 3319000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Accrued Expense: 46669000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Other Current Liabilities: -4266000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: -75844000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Payable: 3319000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 49988000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Prepaid Assets: -8077000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Receivables: -19093000.00
PATH cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -57292000.00
PATH cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: -5039000.00
PATH cash_flow (quarterly, 2025-07-31) — Changes In Cash: -70670000.00
PATH balance_sheet (quarterly, 2025-07-31) — Common Stock: 6000.00
PATH balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 1665703000.00
PATH cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -101576000.00
PATH balance_sheet (quarterly, 2025-07-31) — Construction In Progress: 18762000.00
PATH income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 64380000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 45523000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Assets: 2030736000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 6687000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 6687000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Deferred Assets: 85192000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 514948000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 506948000.00
PATH balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 738417000.00
PATH cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: -1000000.00
PATH cash_flow (quarterly, 2025-07-31) — Deferred Tax: -1000000.00
PATH cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 4230000.00
PATH cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 4230000.00
PATH income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 542865000.00
PATH income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.00
PATH income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 1584000.00
PATH balance_sheet (quarterly, 2025-07-31) — Dueto Related Parties Current: 14102000.00
PATH income_statement (quarterly, 2025-07-31) — EBIT: -20185000.00
PATH income_statement (quarterly, 2025-07-31) — EBITDA: -15955000.00
PATH cash_flow (quarterly, 2025-07-31) — Effect Of Exchange Rate Changes: -1354000.00
PATH cash_flow (quarterly, 2025-07-31) — End Cash Position: 629055000.00
PATH cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -111602000.00
PATH cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 41587000.00
PATH balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: 24747000.00
PATH income_statement (quarterly, 2025-07-31) — General And Administrative Expense: 52889000.00
PATH balance_sheet (quarterly, 2025-07-31) — Goodwill: 120800000.00
PATH balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 142404000.00
PATH balance_sheet (quarterly, 2025-07-31) — Gross Accounts Receivable: 272297000.00
PATH balance_sheet (quarterly, 2025-07-31) — Gross PPE: 150097000.00
PATH income_statement (quarterly, 2025-07-31) — Gross Profit: 297348000.00
PATH cash_flow (quarterly, 2025-07-31) — Income Tax Paid Supplemental Data: 5075000.00
PATH balance_sheet (quarterly, 2025-07-31) — Income Tax Payable: 2166000.00
PATH income_statement (quarterly, 2025-07-31) — Interest Income: 12004000.00
PATH income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 12004000.00
PATH cash_flow (quarterly, 2025-07-31) — Interest Paid Supplemental Data: 0.00
PATH balance_sheet (quarterly, 2025-07-31) — Invested Capital: 1665703000.00
PATH cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: -655000.00
PATH balance_sheet (quarterly, 2025-07-31) — Investmentin Financial Assets: 75151000.00
PATH balance_sheet (quarterly, 2025-07-31) — Investments And Advances: 75151000.00
PATH balance_sheet (quarterly, 2025-07-31) — Leases: 33086000.00
PATH balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 72623000.00
PATH balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 72623000.00
PATH balance_sheet (quarterly, 2025-07-31) — Machinery Furniture Equipment: 31958000.00
PATH cash_flow (quarterly, 2025-07-31) — Net Business Purchase And Sale: 0.00
PATH cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -101576000.00
PATH income_statement (quarterly, 2025-07-31) — Net Income: 1584000.00
PATH income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 1584000.00
PATH income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 1584000.00
PATH income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 1584000.00
PATH income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 1584000.00
PATH cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 1584000.00
PATH income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 1584000.00
PATH income_statement (quarterly, 2025-07-31) — Net Interest Income: 12004000.00
PATH cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: -655000.00
PATH income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: 12004000.00
PATH cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -14102000.00
PATH balance_sheet (quarterly, 2025-07-31) — Net PPE: 107171000.00
PATH cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: 0.00
PATH balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 1523299000.00
PATH balance_sheet (quarterly, 2025-07-31) — Non Current Accounts Receivable: 2659000.00
PATH balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Assets: 161973000.00
PATH balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 104313000.00
PATH balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Revenue: 104313000.00
PATH balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Assets: 26018000.00
PATH income_statement (quarterly, 2025-07-31) — Normalized EBITDA: -15955000.00
PATH income_statement (quarterly, 2025-07-31) — Normalized Income: 1584000.00
PATH cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 41587000.00
PATH income_statement (quarterly, 2025-07-31) — Operating Income: -20185000.00
PATH income_statement (quarterly, 2025-07-31) — Operating Revenue: 361728000.00
PATH balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 530856748.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 52938000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Current Liabilities: 48005000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: 24747000.00
PATH income_statement (quarterly, 2025-07-31) — Other Gand A: 52889000.00
PATH income_statement (quarterly, 2025-07-31) — Other Income Expense: 11508000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Intangible Assets: 21604000.00
PATH cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 19391000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 72223000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 11261000.00
PATH income_statement (quarterly, 2025-07-31) — Other Non Operating Income Expenses: 11508000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Properties: 66291000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Receivables: 117418000.00
PATH balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 818870000.00
PATH balance_sheet (quarterly, 2025-07-31) — Payables: 54417000.00
PATH balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 99940000.00
PATH balance_sheet (quarterly, 2025-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 68837000.00
PATH balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
PATH balance_sheet (quarterly, 2025-07-31) — Prepaid Assets: 57453000.00
PATH income_statement (quarterly, 2025-07-31) — Pretax Income: 3327000.00
PATH cash_flow (quarterly, 2025-07-31) — Proceeds From Stock Option Exercised: 4076000.00
PATH balance_sheet (quarterly, 2025-07-31) — Properties: 0.00
PATH cash_flow (quarterly, 2025-07-31) — Purchase Of Business: 0.00
PATH cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -146706000.00
PATH cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: 0.00
PATH balance_sheet (quarterly, 2025-07-31) — Receivables: 387228000.00
PATH income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 64380000.00
PATH income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 4230000.00
PATH cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -101576000.00
PATH income_statement (quarterly, 2025-07-31) — Research And Development: 98341000.00
PATH balance_sheet (quarterly, 2025-07-31) — Restricted Cash: 438000.00
PATH balance_sheet (quarterly, 2025-07-31) — Retained Earnings: -2008846000.00
PATH cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 146051000.00
PATH income_statement (quarterly, 2025-07-31) — Selling And Marketing Expense: 166303000.00
PATH income_statement (quarterly, 2025-07-31) — Selling General And Administration: 219192000.00
PATH balance_sheet (quarterly, 2025-07-31) — Share Issued: 598628748.00
PATH cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 78006000.00
PATH balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 1665703000.00
PATH balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 1523299000.00
PATH income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 0.00
PATH income_statement (quarterly, 2025-07-31) — Tax Provision: 1743000.00
PATH income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.21
PATH balance_sheet (quarterly, 2025-07-31) — Total Assets: 2592317000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 1665703000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Debt: 79310000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 1665703000.00
PATH income_statement (quarterly, 2025-07-31) — Total Expenses: 381913000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 926614000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 561581000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 188197000.00
PATH income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: -20185000.00
PATH balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 20572000.00
PATH balance_sheet (quarterly, 2025-07-31) — Treasury Shares Number: 67772000.00
PATH balance_sheet (quarterly, 2025-07-31) — Treasury Stock: 824842000.00
PATH balance_sheet (quarterly, 2025-07-31) — Working Capital: 1292319000.00
PATH income_statement (quarterly, 2025-10-31) — +Operating Expense: 329230000.00
PATH income_statement (quarterly, 2025-10-31) — +Total Revenue: 411113000.00
PATH balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 14280000.00
PATH balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 366757000.00
PATH balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -44095000.00
PATH balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 4531257000.00
PATH balance_sheet (quarterly, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -4291000.00
PATH cash_flow (quarterly, 2025-10-31) — Amortization Of Securities: -2085000.00
PATH balance_sheet (quarterly, 2025-10-31) — Available For Sale Securities: 121609000.00
PATH income_statement (quarterly, 2025-10-31) — Basic Average Shares: 532255000.00
PATH income_statement (quarterly, 2025-10-31) — Basic EPS: 0.37
PATH cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 629055000.00
PATH cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -3164000.00
PATH balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 82009000.00
PATH balance_sheet (quarterly, 2025-10-31) — Capital Stock: 6000.00
PATH balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 743660000.00
PATH balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 1398186000.00
PATH cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -11167000.00
PATH cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 100764000.00
PATH cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 28271000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Account Payable: -5695000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Accrued Expense: 20694000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Other Current Liabilities: -1040000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: -7606000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Payable: -5695000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 14999000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Prepaid Assets: 10773000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Receivables: -112579000.00
PATH cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -95453000.00
PATH cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: -98947000.00
PATH cash_flow (quarterly, 2025-10-31) — Changes In Cash: 117868000.00
PATH balance_sheet (quarterly, 2025-10-31) — Common Stock: 6000.00
PATH balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 1924617000.00
PATH cash_flow (quarterly, 2025-10-31) — Common Stock Payments: 0.00
PATH balance_sheet (quarterly, 2025-10-31) — Construction In Progress: 3253000.00
PATH income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 68812000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 46186000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Assets: 2093343000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 9993000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 9993000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Deferred Assets: 86499000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 541998000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 533998000.00
PATH balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 788700000.00
PATH cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: -186950000.00
PATH cash_flow (quarterly, 2025-10-31) — Deferred Tax: -186950000.00
PATH cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 4513000.00
PATH cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 4513000.00
PATH income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 539018000.00
PATH income_statement (quarterly, 2025-10-31) — Diluted EPS: 0.37
PATH income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 198839000.00
PATH balance_sheet (quarterly, 2025-10-31) — Dueto Related Parties Current: 13090000.00
PATH income_statement (quarterly, 2025-10-31) — EBIT: 13071000.00
PATH income_statement (quarterly, 2025-10-31) — EBITDA: 17584000.00
PATH cash_flow (quarterly, 2025-10-31) — Effect Of Exchange Rate Changes: -2825000.00
PATH cash_flow (quarterly, 2025-10-31) — End Cash Position: 744098000.00
PATH cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -11167000.00
PATH cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 25107000.00
PATH balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 27690000.00
PATH income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 53175000.00
PATH balance_sheet (quarterly, 2025-10-31) — Goodwill: 120625000.00
PATH balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 142208000.00
PATH balance_sheet (quarterly, 2025-10-31) — Gross Accounts Receivable: 371048000.00
PATH balance_sheet (quarterly, 2025-10-31) — Gross PPE: 153865000.00
PATH income_statement (quarterly, 2025-10-31) — Gross Profit: 342301000.00
PATH cash_flow (quarterly, 2025-10-31) — Income Tax Paid Supplemental Data: 1451000.00
PATH balance_sheet (quarterly, 2025-10-31) — Income Tax Payable: 9403000.00
PATH income_statement (quarterly, 2025-10-31) — Interest Income: 11701000.00
PATH income_statement (quarterly, 2025-10-31) — Interest Income Non Operating: 11701000.00
PATH cash_flow (quarterly, 2025-10-31) — Interest Paid Supplemental Data: 0.00
PATH balance_sheet (quarterly, 2025-10-31) — Invested Capital: 1924617000.00
PATH cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 100764000.00
PATH balance_sheet (quarterly, 2025-10-31) — Investmentin Financial Assets: 121609000.00
PATH balance_sheet (quarterly, 2025-10-31) — Investments And Advances: 121609000.00
PATH balance_sheet (quarterly, 2025-10-31) — Leases: 51043000.00
PATH balance_sheet (quarterly, 2025-10-31) — Long Term Capital Lease Obligation: 72016000.00
PATH balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 72016000.00
PATH balance_sheet (quarterly, 2025-10-31) — Machinery Furniture Equipment: 33751000.00
PATH cash_flow (quarterly, 2025-10-31) — Net Business Purchase And Sale: 0.00
PATH cash_flow (quarterly, 2025-10-31) — Net Common Stock Issuance: 0.00
PATH income_statement (quarterly, 2025-10-31) — Net Income: 198839000.00
PATH income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 198839000.00
PATH income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 198839000.00
PATH income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 198839000.00
PATH income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 198839000.00
PATH cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 198839000.00
PATH income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 198839000.00
PATH income_statement (quarterly, 2025-10-31) — Net Interest Income: 11701000.00
PATH cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 120767000.00
PATH income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: 11701000.00
PATH cash_flow (quarterly, 2025-10-31) — Net Other Financing Charges: -15406000.00
PATH balance_sheet (quarterly, 2025-10-31) — Net PPE: 109770000.00